Literature DB >> 16565976

Drug abuse in women with eating disorders.

David B Herzog1, Debra L Franko, David J Dorer, Pamela K Keel, Safia Jackson, Mary Pat Manzo.   

Abstract

OBJECTIVE: Drug abuse in women with eating disorders has received relatively little attention. The frequency of drug use disorder (DUD) by specific drug type was examined in the current longitudinal study.
METHOD: In a prospective study, women diagnosed with either anorexia nervosa (AN; n = 136) or bulimia nervosa (BN; n = 110), were interviewed and assessed for research diagnostic criteria (RDC) DUD every 6-12 months over 8.6 years.
RESULTS: Forty-two (17%) women in the current longitudinal study had a lifetime history of DUD, with 19 prospective onsets over the course of the study (9 AN and 10 BN). The most commonly abused illicit drugs were amphetamines, cocaine, and marijuana, and rates of DUD did not differ between intake diagnoses of AN and BN.
CONCLUSION: Drug abuse in women with eating disorders is an area of clinical concern and should be monitored routinely throughout the treatment process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565976     DOI: 10.1002/eat.20257

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  16 in total

1.  Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment.

Authors:  Suzette Glasner-Edwards; Larissa J Mooney; Patricia Marinelli-Casey; Maureen Hillhouse; Alfonso Ang; Richard Rawson
Journal:  Eat Disord       Date:  2011 May-Jun       Impact factor: 3.222

Review 2.  Insulin signaling and addiction.

Authors:  Lynette C Daws; Malcolm J Avison; Sabrina D Robertson; Kevin D Niswender; Aurelio Galli; Christine Saunders
Journal:  Neuropharmacology       Date:  2011-03-21       Impact factor: 5.250

3.  Use transition between illegal drugs among Brazilian university students.

Authors:  João Mauricio Castaldelli-Maia; Silvia S Martins; Lúcio Garcia de Oliveira; Margriet van Laar; Arthur Guerra de Andrade; Sergio Nicastri
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-08-06       Impact factor: 4.328

Review 4.  Neurobiology of aversive states.

Authors:  Erin N Umberg; Emmanuel N Pothos
Journal:  Physiol Behav       Date:  2011-05-01

5.  Binge-like palatable food intake in rats reduces preproglucagon in the nucleus tractus solitarius.

Authors:  Ashmita Mukherjee; Avery Hum; Tyler J Gustafson; Elizabeth G Mietlicki-Baase
Journal:  Physiol Behav       Date:  2020-02-13

6.  Eating disorder symptomatology and substance use disorders: prevalence and shared risk in a population based twin sample.

Authors:  Jessica H Baker; Karen S Mitchell; Michael C Neale; Kenneth S Kendler
Journal:  Int J Eat Disord       Date:  2010-11-01       Impact factor: 4.861

7.  Substance use disorders in women with anorexia nervosa.

Authors:  Tammy L Root; Andréa Poyastro Pinheiro; Laura Thornton; Michael Strober; Fernando Fernandez-Aranda; Harry Brandt; Steve Crawford; Manfred M Fichter; Katherine A Halmi; Craig Johnson; Allan S Kaplan; Kelly L Klump; Maria La Via; James Mitchell; D Blake Woodside; Alessandro Rotondo; Wade H Berrettini; Walter H Kaye; Cynthia M Bulik
Journal:  Int J Eat Disord       Date:  2010-01       Impact factor: 4.861

8.  Patterns of co-morbidity of eating disorders and substance use in Swedish females.

Authors:  T L Root; E M Pisetsky; L Thornton; P Lichtenstein; N L Pedersen; C M Bulik
Journal:  Psychol Med       Date:  2009-04-20       Impact factor: 7.723

9.  Treatment dropout in drug-addicted women: are eating disorders implicated?

Authors:  F Bonfà; S Cabrini; M Avanzi; O Bettinardi; R Spotti; E Uber
Journal:  Eat Weight Disord       Date:  2008-06       Impact factor: 4.652

10.  The relationship between concurrent substance use disorders and eating disorders with personality disorders.

Authors:  Christine Courbasson; Jacqueline M Brunshaw
Journal:  Int J Environ Res Public Health       Date:  2009-07-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.